Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global OTC Consumer Health Products market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
OTC Consumer Health Products market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The OTC Consumer Health Products market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the OTC Consumer Health Products products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of OTC Consumer Health Products products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the OTC Consumer Health Products market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on OTC Consumer Health Products development has been the leading industry trend of OTC Consumer Health Products market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global OTC Consumer Health Products Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Skin Care Products, Oral Care Products, Nutritional Supplements, Wound Care Management Products, Gastrointestinal Products |
| By Application Outlook |
Hospital Pharmacy, Independent Pharmacies, Online Sales, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Pfizer, Inc., American Health, Abbott Laboratories, GlaxosmithKline plc, Ipsen, Sanofi S.A., Bayer AG, Piramal Enterprises Ltd., Sun Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Johnson & Johnson |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Pfizer
- Inc.
- American Health
- Abbott Laboratories
- GlaxosmithKline plc
- Ipsen
- Sanofi S.A.
- Bayer AG
- Piramal Enterprises Ltd.
- Sun Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd.
- Johnson & Johnson
OTC Consumer Health Products Market, By Type
- Skin Care Products
- Oral Care Products
- Nutritional Supplements
- Wound Care Management Products
- Gastrointestinal Products
OTC Consumer Health Products Market, By Application
- Hospital Pharmacy
- Independent Pharmacies
- Online Sales
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 OTC Consumer Health Products Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global OTC Consumer Health Products Market Size Growth Rate by Product
1.4.2 Skin Care Products
1.4.3 Oral Care Products
1.4.4 Nutritional Supplements
1.4.5 Wound Care Management Products
1.4.6 Gastrointestinal Products
1.5 Market by End User
1.5.1 Global OTC Consumer Health Products Market Size Growth Rate by End User
1.5.2 Hospital Pharmacy
1.5.3 Independent Pharmacies
1.5.4 Online Sales
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global OTC Consumer Health Products Market Size
2.1.1 Global OTC Consumer Health Products Revenue 2017-2027
2.1.2 Global OTC Consumer Health Products Sales 2017-2027
2.2 OTC Consumer Health Products Growth Rate by Regions
2.2.1 Global OTC Consumer Health Products Sales by Regions
2.2.2 Global OTC Consumer Health Products Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 OTC Consumer Health Products Sales by Manufacturers
3.1.1 OTC Consumer Health Products Sales by Manufacturers
3.1.2 OTC Consumer Health Products Sales Market Share by Manufacturers
3.1.3 Global OTC Consumer Health Products Market Concentration Ratio (CR5 and HHI)
3.2 OTC Consumer Health Products Revenue by Manufacturers
3.2.1 OTC Consumer Health Products Revenue by Manufacturers (2017-2020)
3.2.2 OTC Consumer Health Products Revenue Share by Manufacturers (2017-2020)
3.3 OTC Consumer Health Products Price by Manufacturers
3.4 OTC Consumer Health Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Consumer Health Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Consumer Health Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Consumer Health Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global OTC Consumer Health Products Sales by Product
4.2 Global OTC Consumer Health Products Revenue by Product
4.3 OTC Consumer Health Products Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global OTC Consumer Health Products Breakdown Data by End User
6 North America
6.1 North America OTC Consumer Health Products by Countries
6.1.1 North America OTC Consumer Health Products Sales by Countries
6.1.2 North America OTC Consumer Health Products Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America OTC Consumer Health Products by Product
6.3 North America OTC Consumer Health Products by End User
7 Europe
7.1 Europe OTC Consumer Health Products by Countries
7.1.1 Europe OTC Consumer Health Products Sales by Countries
7.1.2 Europe OTC Consumer Health Products Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Consumer Health Products by Product
7.3 Europe OTC Consumer Health Products by End User
8 Asia Pacific
8.1 Asia Pacific OTC Consumer Health Products by Countries
8.1.1 Asia Pacific OTC Consumer Health Products Sales by Countries
8.1.2 Asia Pacific OTC Consumer Health Products Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific OTC Consumer Health Products by Product
8.3 Asia Pacific OTC Consumer Health Products by End User
9 Central & South America
9.1 Central & South America OTC Consumer Health Products by Countries
9.1.1 Central & South America OTC Consumer Health Products Sales by Countries
9.1.2 Central & South America OTC Consumer Health Products Revenue by Countries
9.1.3 Brazil
9.2 Central & South America OTC Consumer Health Products by Product
9.3 Central & South America OTC Consumer Health Products by End User
10 Middle East and Africa
10.1 Middle East and Africa OTC Consumer Health Products by Countries
10.1.1 Middle East and Africa OTC Consumer Health Products Sales by Countries
10.1.2 Middle East and Africa OTC Consumer Health Products Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa OTC Consumer Health Products by Product
10.3 Middle East and Africa OTC Consumer Health Products by End User
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer, Inc. OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Pfizer, Inc. OTC Consumer Health Products Products Offered
11.1.5 Pfizer, Inc. Recent Development
11.2 American Health
11.2.1 American Health Company Details
11.2.2 Company Business Overview
11.2.3 American Health OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.2.4 American Health OTC Consumer Health Products Products Offered
11.2.5 American Health Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Company Business Overview
11.3.3 Abbott Laboratories OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Abbott Laboratories OTC Consumer Health Products Products Offered
11.3.5 Abbott Laboratories Recent Development
11.4 GlaxosmithKline plc
11.4.1 GlaxosmithKline plc Company Details
11.4.2 Company Business Overview
11.4.3 GlaxosmithKline plc OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.4.4 GlaxosmithKline plc OTC Consumer Health Products Products Offered
11.4.5 GlaxosmithKline plc Recent Development
11.5 Ipsen, Sanofi S.A.
11.5.1 Ipsen, Sanofi S.A. Company Details
11.5.2 Company Business Overview
11.5.3 Ipsen, Sanofi S.A. OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Ipsen, Sanofi S.A. OTC Consumer Health Products Products Offered
11.5.5 Ipsen, Sanofi S.A. Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Company Business Overview
11.6.3 Bayer AG OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Bayer AG OTC Consumer Health Products Products Offered
11.6.5 Bayer AG Recent Development
11.7 Piramal Enterprises Ltd.
11.7.1 Piramal Enterprises Ltd. Company Details
11.7.2 Company Business Overview
11.7.3 Piramal Enterprises Ltd. OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Piramal Enterprises Ltd. OTC Consumer Health Products Products Offered
11.7.5 Piramal Enterprises Ltd. Recent Development
11.8 Sun Pharmaceuticals Ltd.
11.8.1 Sun Pharmaceuticals Ltd. Company Details
11.8.2 Company Business Overview
11.8.3 Sun Pharmaceuticals Ltd. OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Sun Pharmaceuticals Ltd. OTC Consumer Health Products Products Offered
11.8.5 Sun Pharmaceuticals Ltd. Recent Development
11.9 Glenmark Pharmaceuticals Ltd.
11.9.1 Glenmark Pharmaceuticals Ltd. Company Details
11.9.2 Company Business Overview
11.9.3 Glenmark Pharmaceuticals Ltd. OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Glenmark Pharmaceuticals Ltd. OTC Consumer Health Products Products Offered
11.9.5 Glenmark Pharmaceuticals Ltd. Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Business Overview
11.10.3 Johnson & Johnson OTC Consumer Health Products Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Johnson & Johnson OTC Consumer Health Products Products Offered
11.10.5 Johnson & Johnson Recent Development
12 Future Forecast
12.1 OTC Consumer Health Products Market Forecast by Regions
12.1.1 Global OTC Consumer Health Products Sales Forecast by Regions 2019-2025
12.1.2 Global OTC Consumer Health Products Revenue Forecast by Regions 2019-2025
12.2 OTC Consumer Health Products Market Forecast by Product
12.2.1 Global OTC Consumer Health Products Sales Forecast by Product 2019-2025
12.2.2 Global OTC Consumer Health Products Revenue Forecast by Product 2019-2025
12.3 OTC Consumer Health Products Market Forecast by End User
12.4 North America OTC Consumer Health Products Forecast
12.5 Europe OTC Consumer Health Products Forecast
12.6 Asia Pacific OTC Consumer Health Products Forecast
12.7 Central & South America OTC Consumer Health Products Forecast
12.8 Middle East and Africa OTC Consumer Health Products Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 OTC Consumer Health Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
